COMMUNIQUÉS West-GlobeNewswire

Breakthrough Therapy Designation granted by the FDA for daridorexant in pediatric insomnia disorder
04/11/2026
The FDA recognizes through this designation both the clinical evidence supporting daridorexant and the significant unmet medical need in pediatric insomnia, where no FDA-approved pharmacological treatments are currently [...]
German hospital introduces miscarriage care device
04/11/2026
New device offers dignified support for early pregnancy loss HAMBURG, Nov. 04, 2026 (GLOBE NEWSWIRE) -- A HOSPITAL in northern Germany has become the first in mainland Europe to offer an innovative medical device [...]
Novo raises full-year outlook on continued GLP-1 momentum, with third-quarter adjusted operating profit increasing 27% at CER to DKK 31,720 million
04/11/2026
4 November - Financial report for the period 1 January 2026 to 30 September 2026 Financial performance Q3 2026 adjusted and reported sales increased by 4% at CER, driven by continued GLP-1 volume growth across the US [...]
Eliminating Static Without Electricity - MEC Industries Introduces the Powerless ECO Ionizer
04/11/2026
Powerless ECO Ionizer Eliminates Static Without Electricity SEOUL, South Korea, Nov. 03, 2026 (GLOBE NEWSWIRE) -- MEC Industries introduces the Powerless ECO Ionizer , a static-control device that operates without an [...]
ElderVoice Reports Its AI Phone Companion Alerted a Daughter After Her Mother Said She Was Panicking
04/11/2026
ElderVoice calls older adults on the phone they already own and texts their family when a call raises a serious worry. Early families say their parents feel less alone. Austin, TX, Nov. 03, 2026 (GLOBE NEWSWIRE) -- A 76 [...]
Pennant Announces Third Quarter 2026 Earnings Release and Call
04/11/2026
EAGLE, Idaho, Nov. 03, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it [...]
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/11/2026
MONTREAL and CHARLOTTE, N.C., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today announced that the Company granted equity awards, in the form of a [...]
Aquestive Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
03/11/2026
Anaphylm resubmission accepted with PDUFA goal date of March 16, 2027 Anaphylm would be the first and only oral rescue medication for the treatment of severe allergic reactions, including anaphylaxis, if approved [...]
Ultragenyx Reports Third Quarter 2026 Financial Results, Announces Substantial Expense Reductions, and Reaffirms Profitability in 2027
03/11/2026
Third quarter total revenue of $173 million, CRYSVITA® revenue of $109 million and DOJOLVI® revenue of $30 million GENGLYCOS™ and FAYUVI™ BLAs approved by FDA in the third quarter Two Priority Review Vouchers (PRVs) [...]
Denali Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights
03/11/2026
AVLAYAH® (tividenofusp alfa-eknm) net product revenue accelerated to $17.8 million in its second full commercial quarter Continued growth expectations drive Q4 2026 net product revenue guidance of $30.0 million to $32.0 [...]
Ardelyx Reports Third Quarter 2026 Financial Results and Provides Business Update
03/11/2026
Q3 2026 total product revenue of $125.5 million , reflecting 19% growth year-over-year IBSRELA Q3 2026 revenue growth of 23% year-over-year to $96.3 million Strong financial position with $285.3 million in cash, cash [...]
Xenon to Present at Upcoming Investor Conferences
03/11/2026
VANCOUVER, BC and BOSTON, MA, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and [...]
Nurix Therapeutics Announces Sanofi’s Decision to Discontinue Development of STAT6 Degrader SAR448272
03/11/2026
BRISBANE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on targeted protein degradation medicines, today announced that Sanofi [...]
Monte Rosa Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/11/2026
BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the grant of [...]
Spyre Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
03/11/2026
Announced positive topline induction data for SPY003 from Part A of the Phase 2 SKYLINE trial (“SKYLINE”), completing proof-of-concept for all three monotherapies in inflammatory bowel disease (“IBD”). SKYLINE Part B is [...]
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
03/11/2026
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing and commercializing treatments that address [...]
Aura Biosciences to Participate in Upcoming Investor Conference
03/11/2026
BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a potentially transformative first-in-class therapy for patients with ocular cancers, [...]
Globus Medical Acquires Synaptive Medical, Strengthening Its Position in Cranial Neurosurgery
03/11/2026
AUDUBON, Pa., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. a leading musculoskeletal technology company, today announced that it completed the acquisition of Synaptive Medical, deepening the Company's presence [...]
Alamar Biosciences Partners with GSK on Large-Scale Proteomic Study to Advance Precision Medicine
03/11/2026
Alamar’s NULISAseq™ Immune 340 and NULISAseq™ Neuro 220 panels will be used to investigate disease progression, biological subtypes and treatment response FREMONT, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Alamar [...]

Pages